Related Experiment Video
Updated: Dec 10, 2025
08:40
Preparation of Tumor Antigen-loaded Mature Dendritic Cells for Immunotherapy
Published on: August 1, 2013
18.5K
Emerging Adjuvants for Cancer Immunotherapy
Hong-Guo Hu1, Yan-Mei Li1,2,3
1Key Lab of Bioorganic Phosphorus Chemistry and Chemical Biology, Department of Chemistry, Tsinghua University, Beijing, China.
Frontiers in Chemistry
|August 28, 2020
Summary
Emerging adjuvants show promise for enhancing cancer immunotherapy and vaccines by improving immune activation and cancer cell death. Researchers are developing safer, more effective adjuvants to overcome current limitations in cancer treatment.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Background:
- Cancer immunotherapy utilizes adjuvants to boost immune responses against cancer.
- Adjuvants are critical for therapeutic cancer vaccines, enhancing antigen presentation and T cell activity.
- Current adjuvants face limitations due to suboptimal efficacy and safety profiles.
Purpose of the Study:
- To review the discovery and structural design of novel adjuvants for cancer immunotherapy.
- To highlight advancements in developing safe and effective adjuvant compounds.
- To discuss the implications of emerging adjuvants for healthcare and cancer treatment.
Main Methods:
- Literature review focusing on recent studies of adjuvant discovery and development.
- Analysis of various compound classes (inorganic, organic, polymers, colloids) as adjuvant candidates.
- Examination of adjuvant mechanisms targeting immune activation pathways.
Main Results:
- Identification of diverse chemical entities optimized as immune agonists.
- Progress in designing adjuvants with improved safety and efficacy profiles.
- Demonstration of enhanced adaptive immune responses, including cytotoxic T lymphocyte induction.
Conclusions:
- Emerging adjuvants represent a significant advancement in cancer immunotherapy.
- Structural design and discovery of novel adjuvants are crucial for overcoming treatment limitations.
- These developments hold substantial promise for improving patient outcomes in cancer care.
Related Concept Videos
01:27Tumor Immunotherapy
1.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.5K
01:30Cancer Vaccines
857
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
857
02:53Adaptive Mechanisms in Cancer Cells
6.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.7K
01:26Antigens Involved in Adaptive Immunity
1.1K
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
Complete Antigens
Complete antigens possess both immunogenicity and...
1.1K
02:57Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K
02:49Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K